EMJ GOLD

AbbVie has partnered with McLaren Racing, pledging to make donations to patient advocacy groups in line with the team’s on-track performance.

Women-specific cardiovascular research received just €150,000 in EU funding since 2021, a stark contrast to areas like breast cancer.

AstraZeneca and insitro will use AI to discover potential treatments for MASH and cardiomyopathies.

First Tracks Biotherapeutics’ experimental treatment reduced symptoms and helped prevent gut damage after gluten exposure.

The MHRA’s new strategy highlights how real-world evidence, AI-driven analysis, and clinician reporting could support better patient outcomes across healthcare. MHRA Chair, Anthony Harnden, shares his insights.

Bristol Myers’ RYZ101 improved progression-free survival in a Phase 3 trial for advanced neuroendocrine tumours.

Nvidia-backed Iambic seeks up to $159.4m in a US IPO as it develops experimental cancer treatments using AI.

The UK’s MHRA welcomes the ASA’s first bans on oral weight-loss medicine adverts and warns advertisers over rule breaches.